Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Current Assets: 2017-2025

Historic Current Assets for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $143.6 million.

  • Puma Biotechnology's Current Assets fell 8.44% to $143.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.6 million, marking a year-over-year decrease of 8.44%. This contributed to the annual value of $147.7 million for FY2024, which is 5.46% down from last year.
  • As of Q3 2025, Puma Biotechnology's Current Assets stood at $143.6 million, which was up 5.13% from $136.6 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Current Assets high stood at $167.8 million for Q2 2021, and its period low was $111.8 million during Q1 2023.
  • Moreover, its 3-year median value for Current Assets was $137.7 million (2024), whereas its average is $137.2 million.
  • Per our database at Business Quant, Puma Biotechnology's Current Assets crashed by 31.88% in 2022 and then rose by 27.98% in 2024.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Current Assets stood at $140.0 million in 2021, then declined by 4.10% to $134.3 million in 2022, then increased by 16.31% to $156.2 million in 2023, then dropped by 5.46% to $147.7 million in 2024, then declined by 8.44% to $143.6 million in 2025.
  • Its Current Assets stands at $143.6 million for Q3 2025, versus $136.6 million for Q2 2025 and $132.5 million for Q1 2025.